chr19-6743834-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001288962.2(TRIP10):c.640G>A(p.Asp214Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000868 in 1,613,480 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001288962.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TRIP10 | NM_001288962.2 | c.640G>A | p.Asp214Asn | missense_variant, splice_region_variant | 7/15 | ENST00000313244.14 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TRIP10 | ENST00000313244.14 | c.640G>A | p.Asp214Asn | missense_variant, splice_region_variant | 7/15 | 1 | NM_001288962.2 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151820Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000279 AC: 7AN: 250572Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135498
GnomAD4 exome AF: 0.00000821 AC: 12AN: 1461660Hom.: 0 Cov.: 34 AF XY: 0.00000825 AC XY: 6AN XY: 727148
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151820Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74108
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 11, 2023 | The c.640G>A (p.D214N) alteration is located in exon 7 (coding exon 7) of the TRIP10 gene. This alteration results from a G to A substitution at nucleotide position 640, causing the aspartic acid (D) at amino acid position 214 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at